Figure 2.

The multiple sequence alignment of known commercial antibodies s used for determining the light (top) and heavy chain (middle) complementarity determining regions (CDRs). An example showing Vκ3 framework region determination is as shown (bottom). For the full list, refer to Data S2–S16 in Supplementary Material.